Manufacturing Chemist: Making the case for the strategic outsourcing of serialisation

Despite the European Falsified Medicines Directive (FMD) deadline being less than six months away, many companies are not on track to meet compliance in time. In an article for Manufacturing Chemist, Daniel Tedham, managing director Wasdell Manufacturing, discusses the upcoming challenges of serialisation and offers possible solutions for companies that are behind in their preparations. Find out more here:

Comments are currently closed.